Friends and colleagues,
Please join us at the ESMO Asia Congress 2022, organised by the European Society for Medical Oncology, from 2-4 December 2022. On this page you’ll find information on our latest news and updates we will be sharing.
We’re excited to partner pharmas and physicians to improve patient access by advanced, affordable and accurate next-generation sequencing (NGS) testing. Our team will be present at booth E207 and we hope you will get in touch.
We’re looking forward to seeing you in person.
Lucence shares results of NGS test performance on CSF specimen of lung cancer patients during ESMO Asia Congress 2022.
Lucence is glad to share how accurate and affordable ctDNA and ctRNA panels speeds drug development and improves access.
Sign up for the latest news and updates about Lucence at ESMO Asia 2022. For questions, email us at [email protected].